Literature DB >> 14605051

Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia.

Steven H Silber1, Christopher Garrett, Rakesh Singh, Angela Sweeney, Carl Rosenberg, Diana Parachiv, Tobi Okafo.   

Abstract

STUDY
OBJECTIVE: To determine if there is a statistically significant difference in the time to clinical stability (TCS) between those patients with moderate-to-severe (MTS) community-acquired pneumonia (CAP) who received their antibiotics within 4 h and those who received their antibiotics after 4 h.
DESIGN: Prospective observational study.
SETTING: A large metropolitan teaching institution with 62,000 annual emergency department visits from May 1999 through January 2001. PATIENTS: Patients were > or = 21 year with MTS CAP as defined by the Pneumonia Patient Outcomes Research Team (PORT).
INTERVENTIONS: Triage-to-needle time (group 1, 0 to 240 min; group 2, 241 to 480 min; and group 3, > 480 min) was the independent variable, and TCS was the dependent variable. Our hypothesis was that door-to-needle time < 4 h would result in TCS reduction of 0.5 days. MEASUREMENTS: Statistical analysis was performed using the two-tailed Student t test, analysis of variance, and multiple linear regression; p < 0.05 was considered significant.
RESULTS: Four hundred nine patients with MTS CAP achieved clinical stability during their hospital stay. Fifty-four percent of patients received antibiotics within 4 h. The mean time to receiving antibiotics was 131.46 min (2.19 h) in group 1, 335.52 min (5.59 h) in group 2, and 783.98 min (13.07 h) in group 3. Mean TCS was 3.19 days in group 1, 3.16 days in group 2, and 3.29 days in group 3. There were no statistically significant differences in TCS between the study groups.
CONCLUSION: The administration of antibiotics within 4 h does not reduce the TCS in adult patients with MTS-CAP, as defined by the PORT group. Future studies using other physiologic parameters should be explored.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605051     DOI: 10.1378/chest.124.5.1798

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  17 in total

1.  A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia.

Authors:  Philippe Jaoude; Jessica Badlam; Anil Anandam; Ali A El-Solh
Journal:  Intern Emerg Med       Date:  2012-03-06       Impact factor: 3.397

2.  Processes of care and outcomes for community-acquired pneumonia.

Authors:  Jonathan S Lee; Brian A Primack; Maria K Mor; Roslyn A Stone; D Scott Obrosky; Donald M Yealy; Michael J Fine
Journal:  Am J Med       Date:  2011-10-13       Impact factor: 4.965

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

4.  Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Authors:  Cédric Bretonnière; Marc Leone; Christophe Milési; Bernard Allaouchiche; Laurence Armand-Lefevre; Olivier Baldesi; Lila Bouadma; Dominique Decré; Samy Figueiredo; Rémy Gauzit; Benoît Guery; Nicolas Joram; Boris Jung; Sigismond Lasocki; Alain Lepape; Fabrice Lesage; Olivier Pajot; François Philippart; Bertrand Souweine; Pierre Tattevin; Jean-François Timsit; Renaud Vialet; Jean Ralph Zahar; Benoît Misset; Jean-Pierre Bedos
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

5.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

6.  The Roles of the Charlson Comorbidity Index and Time to First Antibiotic Dose as Predictors of Outcome in Pneumococcal Community-Acquired Pneumonia.

Authors:  Daniel Franzen; Marisa Lim; Daniel J Bratton; Stefan P Kuster; Malcolm Kohler
Journal:  Lung       Date:  2016-07-12       Impact factor: 2.584

7.  [Pneumonia in the elderly: results of quality improvement program for a geriatric department in Lower Saxony 2006-2009].

Authors:  M Gogol; D Schmidt; A Dettmer-Flügge; B Vaske
Journal:  Z Gerontol Geriatr       Date:  2011-08       Impact factor: 1.281

8.  Reducing door-to-antibiotic time in community-acquired pneumonia: Controlled before-and-after evaluation and cost-effectiveness analysis.

Authors:  Gavin Barlow; Dilip Nathwani; Fiona Williams; Simon Ogston; John Winter; Michael Jones; Peter Slane; Elizabeth Myers; Frank Sullivan; Nicola Stevens; Rebecca Duffey; Karen Lowden; Peter Davey
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

9.  Time to clinical stability among children hospitalized with pneumonia.

Authors:  Rachel B Wolf; Kathryn Edwards; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; James Chappell; Anna M Bramley; Seema Jain; Derek J Williams
Journal:  J Hosp Med       Date:  2015-04-28       Impact factor: 2.960

10.  Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia.

Authors:  A H W Bruns; J J Oosterheert; W N M Hustinx; C A J M Gaillard; E Hak; A I M Hoepelman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-03-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.